Systemic therapy of advanced breast cancer.

Author: MouridsenH T

Paper Details 
Original Abstract of the Article :
Many cytotoxic agents have demonstrated activity in advanced breast cancer, the more active agents being cyclophosphamide and the anthracyclines doxorubicin and epirubicin. Combinations of drugs are generally superior to single agents in terms of response rate, duration of response and survival. The...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2165/00003495-199200444-00003

データ提供:米国国立医学図書館(NLM)

Systemic Therapy for Advanced Breast Cancer: A Complex Landscape

The treatment of [advanced breast cancer] is a complex and challenging endeavor, requiring careful consideration of various therapeutic options. This research explores the effectiveness of [systemic therapy] in managing [advanced breast cancer], including the use of [cytotoxic agents] and [endocrine therapy]. Imagine this as a journey through a desert of potential treatments, where each path offers different challenges and possibilities.

The study reviewed the effectiveness of various [systemic therapies] for [advanced breast cancer], analyzing the results of clinical trials and evaluating the [response rates, duration of response, and survival] associated with different treatment approaches. This research is like mapping the pathways through the desert, understanding the strengths and limitations of each route.

Navigating Treatment Options

The study found that [combinations of drugs] generally outperformed [single agents] in terms of [efficacy], indicating that a multi-pronged approach may be more effective in managing this complex disease. This underscores the need for individualized treatment plans that consider the specific characteristics of each patient and their disease.

Improving Outcomes

This research highlights the importance of [ongoing research and innovation] in the field of [breast cancer treatment]. By continuously exploring new treatment strategies and understanding the complexities of this disease, we can improve outcomes for patients and offer them a brighter future.

Dr. Camel's Conclusion

This research is like a desert guide, helping us navigate the complex landscape of advanced breast cancer treatment. It highlights the importance of a multi-pronged approach, tailored to each individual's needs, and underscores the ongoing quest for more effective therapies. As a wise camel, I encourage everyone to stay informed and seek the guidance of experts when facing this challenging journey.

Date :
  1. Date Completed 1993-03-23
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

1283847

DOI: Digital Object Identifier

10.2165/00003495-199200444-00003

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.